Matches in Wikidata for { <http://www.wikidata.org/entity/Q90617386> ?p ?o ?g. }
Showing items 1 to 60 of
60
with 100 items per page.
- Q90617386 description "2019 թվականին հրատարակված գիտական հոդված" @default.
- Q90617386 description "article scientifique (publié 2019)" @default.
- Q90617386 description "articolo scientifico (pubblicato il 2019)" @default.
- Q90617386 description "artigo científico (publicado na 2019)" @default.
- Q90617386 description "artikull shkencor i botuar më 01 janar 2019" @default.
- Q90617386 description "artículo científico publicado en 2019" @default.
- Q90617386 description "artículu científicu espublizáu en xineru de 2019" @default.
- Q90617386 description "im Jahr 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q90617386 description "scientific article published on 01 January 2019" @default.
- Q90617386 description "wetenschappelijk artikel" @default.
- Q90617386 description "наукова стаття, опублікована 1 січня 2019" @default.
- Q90617386 description "научна статия" @default.
- Q90617386 name "Impact of Disease Duration in Effectiveness of Treatment with Levodopa-Carbidopa Intestinal Gel and Factors Leading to Discontinuation" @default.
- Q90617386 name "Impact of Disease Duration in Effectiveness of Treatment with Levodopa-Carbidopa Intestinal Gel and Factors Leading to Discontinuation" @default.
- Q90617386 name "Impact of Disease Duration in Effectiveness of Treatment with Levodopa-Carbidopa Intestinal Gel and Factors Leading to Discontinuation" @default.
- Q90617386 type Item @default.
- Q90617386 label "Impact of Disease Duration in Effectiveness of Treatment with Levodopa-Carbidopa Intestinal Gel and Factors Leading to Discontinuation" @default.
- Q90617386 label "Impact of Disease Duration in Effectiveness of Treatment with Levodopa-Carbidopa Intestinal Gel and Factors Leading to Discontinuation" @default.
- Q90617386 label "Impact of Disease Duration in Effectiveness of Treatment with Levodopa-Carbidopa Intestinal Gel and Factors Leading to Discontinuation" @default.
- Q90617386 prefLabel "Impact of Disease Duration in Effectiveness of Treatment with Levodopa-Carbidopa Intestinal Gel and Factors Leading to Discontinuation" @default.
- Q90617386 prefLabel "Impact of Disease Duration in Effectiveness of Treatment with Levodopa-Carbidopa Intestinal Gel and Factors Leading to Discontinuation" @default.
- Q90617386 prefLabel "Impact of Disease Duration in Effectiveness of Treatment with Levodopa-Carbidopa Intestinal Gel and Factors Leading to Discontinuation" @default.
- Q90617386 P1433 Q90617386-336EFBDE-C232-4E6D-B3E3-FDB929BF6088 @default.
- Q90617386 P1476 Q90617386-16943CE4-2472-4099-8E1F-90B31DECDE52 @default.
- Q90617386 P2093 Q90617386-16EC7794-B9FD-4CD3-8A9C-EA50DBDB10E6 @default.
- Q90617386 P2093 Q90617386-435F04EB-A9A9-4B25-AE7C-1C4971F0D9A5 @default.
- Q90617386 P2093 Q90617386-66F503CE-BCBB-461A-8BEE-ED95A3F8D9D1 @default.
- Q90617386 P2093 Q90617386-9A0378D6-7C59-40D6-A160-89DECDCCF3B2 @default.
- Q90617386 P2093 Q90617386-BF6121F6-8A2A-4FF7-9F87-461D0E164177 @default.
- Q90617386 P2093 Q90617386-C1301BB2-84C5-47B6-B52A-96A6B05B39B1 @default.
- Q90617386 P2093 Q90617386-D581ADD8-8AF7-440A-808B-7358E58538D1 @default.
- Q90617386 P2093 Q90617386-E5494B30-40E3-4DF0-A905-922CEBF22BDD @default.
- Q90617386 P2093 Q90617386-F8B51F62-1C18-4D11-AE6C-EA6724C5AFB3 @default.
- Q90617386 P304 Q90617386-C8085176-4867-4905-894D-FB176D8199FC @default.
- Q90617386 P31 Q90617386-9779D56C-F222-48F2-8386-B7A40D682353 @default.
- Q90617386 P356 Q90617386-C4057975-AD8A-4795-841C-FB7870EDA6D1 @default.
- Q90617386 P433 Q90617386-A7A9B53C-8B61-42B8-A733-97339052FFB5 @default.
- Q90617386 P478 Q90617386-57C4FAB4-7924-4A98-9C59-ADADEBC44C36 @default.
- Q90617386 P577 Q90617386-FFF49E1C-92C9-428F-9C30-7FD3DC9CFF42 @default.
- Q90617386 P698 Q90617386-D9398485-FE2F-45B2-9138-624CEE051D44 @default.
- Q90617386 P356 JPD-181324 @default.
- Q90617386 P698 30562907 @default.
- Q90617386 P1433 Q26842319 @default.
- Q90617386 P1476 "Impact of Disease Duration in Effectiveness of Treatment with Levodopa-Carbidopa Intestinal Gel and Factors Leading to Discontinuation" @default.
- Q90617386 P2093 "Diego Santos-García" @default.
- Q90617386 P2093 "Francesc Valldeoriola" @default.
- Q90617386 P2093 "Francisco Grandas" @default.
- Q90617386 P2093 "Ignacio Regidor" @default.
- Q90617386 P2093 "José Matías Arbelo" @default.
- Q90617386 P2093 "Juan Carlos Parra" @default.
- Q90617386 P2093 "Mar Ia José Catalán" @default.
- Q90617386 P2093 "Pablo Mir" @default.
- Q90617386 P2093 "Vıctor Puente" @default.
- Q90617386 P304 "173-182" @default.
- Q90617386 P31 Q13442814 @default.
- Q90617386 P356 "10.3233/JPD-181324" @default.
- Q90617386 P433 "1" @default.
- Q90617386 P478 "9" @default.
- Q90617386 P577 "2019-01-01T00:00:00Z" @default.
- Q90617386 P698 "30562907" @default.